Trial intelligence / Profile preview

Roxadustat in ESA-naive Hemodialysis Patients With Anemia

NCT02780141Phase 3Completed

Sponsor
Astellas Pharma
Start
Jun 2016
Primary completion
Dec 2017
Countries
1
01

Overview

A Phase 3 trial of roxadustat in anemia, sponsored by Astellas Pharma. Started Jun 2016; status: completed.

02

Drugs

roxadustat
03

Conditions

anemia

Beyond the preview

Go deeper on NCT02780141.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02780141.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call